IGF1R and neoplasm: The phosphorylation of ERK (Figure 4D, left) and expression of IGF1R (Figure 4D, right) was decreased in tumor lysates from SK-N-AS and NB-Eb-C1 xenografts treated with trametinib and ganitumab, indicating that the in vitro mechanisms of action of each of these drugs was preserved in vivo.